Filing Details

Accession Number:
0001445866-14-001130
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2014-09-05 17:58:41
Reporting Period:
2014-09-05
Filing Date:
2014-09-05
Accepted Time:
2014-09-05 17:58:41
Original Submission Date:
2014-09-05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006045 Iridex Corp IRIX Electromedical & Electrotherapeutic Apparatus (3845) 770210467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1311443 Blueline Partners, L.l.c. 3480 Buskirk Avenue
Suite 214
Pleasant Hill CA 94523
Yes No Yes No
1338149 Blueline Capital Partners, L.p. 3480 Buskirk Avenue
Suite 214
Pleasant Hill CA 94523
Yes No Yes No
1411986 Blueline Capital Partners Iii, Lp 3480 Buskirk Avenue
Suite 214
Pleasant Hill CA 94523
Yes No Yes No
1411987 Blueline Partners Ii, Llc 3480 Buskirk Avenue
Suite 214
Pleasant Hill CA 94523
Yes No Yes No
1460518 Blueline Catalyst Fund Ix, L.p. 3480 Buskirk Avenue
Suite 214
Pleasant Hill CA 94523
Yes No Yes No
1460781 Blueline Capital Partners Ii, L.p. 3480 Buskirk Avenue
Suite 214
Pleasant Hill CA 94523
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-03 300 $7.98 2,522,105 No 4 P Direct
Common Stock Acquisiton 2014-09-04 200 $7.99 2,522,305 No 4 P Direct
Common Stock Acquisiton 2014-09-05 7,932 $7.99 2,530,237 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. These securities were acquired by BlueLine Catalyst Fund IX, L.P. As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities.